GL1X · GenesisL1 explorer

Research workbench

The solution structure of a trisaccharide-antibody complex: comparison of NMR measurements with a crystal structure

Analyse The solution structure of a trisaccharide-antibody complex: comparison of NMR… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1MFD
Type
protein
Length
423 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
IGG1-lambda SE155-4 Fab (light chain); IGG1-lambda SE155-4 Fab (heavy chain)
Ligands
ABE, MMA, GLA
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LIGG1-lambda SE155-4 Fab (light chain)protein2127% helix, 56% strand—
HIGG1-lambda SE155-4 Fab (heavy chain)protein21110% helix, 54% strand—

Ligands and binding sites

  • ABE · alpha-D-Abequopyranose · ligand · chains L, H
  • MMA · methyl alpha-D-mannopyranoside · sugar · chains H
  • GLA · alpha-D-galactopyranose · sugar · chains L, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16260.660.7659empty
2540.390.8014ABE

Interfaces

1 interface between chains.

  • L–H · 1836 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1MFD · The solution structure of a trisaccharide-antibody complex: comparison of NMR… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.